SGX Just Hit a Record Year. UOB Kay Hian Still Won't Say Buy, and Neither Will Our Yield Floor
UOB Kay Hian's own numbers show why a S$23.40 target and a HOLD rating aren't in conflict.
A company can report its best year in history and still fail the one number that decides whether it belongs in a retirement portfolio. SGX just did exactly that. Record profit, a 52% bigger dividend, and an institutional analyst raising its earnings forecast, and the rating on the table is still HOLD, not BUY.
I run every stock through the same forensic screen regardless of how good the headline looks, because a strong business and a fairly priced income stream are two different questions. SGX’s FY26 results answer the first one emphatically. What they don’t answer is whether today’s price pays you enough to hold it for retirement income. Let’s look at what the analyst actually said before we get to what our screen found.
Section 1: The Analyst’s Case
Section 2: Iggy’s Forensic Screen
Financial Health Checklist
Section 3: The Dividend Trajectory
Section 4: The Forensic Gap
Insight Callout Box 1
Section 5: What To Watch Next
Insight Callout Box 2
🟠 IGGY’S FORENSIC ZONE
Section 1: The Analyst’s Case
UOB Kay Hian’s note on SGX is unambiguously positive on the business.
FY26 net profit came in at S$698.4 million, up 7.8% year on year, while UOBKH’s own adjusted core net profit measure showed S$759.5 million, up 24.6% and beating their own forecast by 2.8%. Net revenue rose 13.9% to S$1.48 billion, with FICC revenue up 17.0%, cash equities up a striking 28.1%, and platform services up 7.0%. The one soft spot, equity derivatives, dipped just 0.4%, barely worth mentioning against everything else.
Cost discipline stood out as a genuine positive: adjusted operating expenses rose only 5.5% against 13.9% revenue growth, pushing core operating margin up 3.1 percentage points to 61.3%. That’s the kind of operating leverage that makes analysts raise numbers, and UOBKH did exactly that, lifting FY27-28 earnings forecasts by 4-5% to S$860 million and S$896 million respectively, with FY27 core earnings projected to grow 13.2%.
Trading activity was broad-based rather than concentrated in one product line. Securities daily average value rose 34.9% to S$1.8 billion, FICC contract volume grew 26.0%, equity derivatives volume grew 6.4%. The report attributes this to stronger investor flows into Singapore equities and rising demand across SGX’s currency, commodity, and index derivatives suite. Looking forward, UOBKH points to a roughly 50-deal IPO pipeline, market structure reforms, and expansion into FX, commodities, OTC clearing, and gold-related products as continued growth drivers, with management reiterating 6-8% medium-term revenue growth guidance.
None of this is in dispute. UOBKH isn’t questioning SGX’s operational trajectory anywhere in this note.
THE LOAD-BEARING ASSUMPTION: the HOLD rating rests entirely on valuation, not operations. SGX trades at a projected 29.0x FY28 P/E, above global exchange peers at roughly 20-26x. UOBKH’s own S$23.40 target price is built on 27.9x FY28 earnings, a multiple the firm itself notes sits two standard deviations above SGX’s five-year historical average of 22.5x. The analyst isn’t disputing the business. The analyst is saying the price already assumes a lot of the good news has arrived.
Section 2: Iggy’s Forensic Screen
Our framework runs a parallel test, independent of any analyst’s price target: does this stock’s actual yield clear the bar a retiree needs it to clear? For SGX, the answer isn’t close.
At a share price of S$24.51, SGX’s confirmed FY26 total dividend of 57.0 cents per share produces a trailing yield of 2.33%. Strip out the 12.5-cent one-off capital-recycling dividend, since that’s explicitly a non-recurring distribution tied to a specific corporate action rather than an ongoing payout commitment, and the ordinary-only yield falls to 1.82%.
Both figures sit meaningfully below our 3.2% forensic floor, the deliberately conservative baseline every stock in our coverage is tested against before we even reach the 4.7% minimum hurdle for retirement income. This isn’t a narrow miss on an aggressive target. It’s a floor breach on either basis you choose to compute it.
Financial Health Checklist
Here’s where SGX genuinely earns its reputation as a fortress balance sheet, and where our screen agrees with UOBKH’s own framing. Gearing sits comfortably under any reasonable ceiling at 28.6% debt-to-equity. More strikingly, SGX carries S$1.56 billion in net cash, meaning it holds meaningfully more cash and short-term investments than it owes in interest-bearing debt.
Standard interest coverage mechanics don’t really apply here in the way they would for a REIT or an industrial company: SGX’s interest income of S$41.6 million actually exceeds its interest expense of S$16.6 million, producing S$25.0 million in net interest income for the year. This is a company earning money on its own balance sheet position, not straining to service debt.
That combination, a passing balance sheet and a failing yield, is precisely the case our framework is built to isolate. A weak balance sheet failure and a fair-priced-income failure would be a compound problem. This is neither. This is a single, clean cause: the price you’d pay today for SGX shares simply doesn’t generate enough cash yield to clear our floor, regardless of how sound the underlying business is.
SGX passes the balance-sheet tests cleanly. The 12.5-cent one-off dividend is the calculation that determines whether its headline yield can be trusted.
